Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson’s diseaseA [11C]-raclopride PET study

被引：0
|
作者：
S. Thobois
V. Fraix
M. Savasta
N. Costes
P. Pollak
P. Mertens
A. Koudsie
D. Le Bars
A. L. Benabid
E. Broussolle
机构：
[1] Hôpital Neurologique Pierre Wertheimer,Dept. of Neurology D (Pr. G. Chazot) and INSERM U 534
[2] CHU,Dept. of Neurology and Neurosurgery
[3] Cyclotron Unit,CERMEP
[4] Hôpital Neurologique Pierre Wertheimer,Dept. of Neurosurgery A (Pr. M. Sindou)
[5] CHU,INSERM U 318
来源：
Journal of Neurology | 2003年 / 250卷
关键词：
Parkinson’s disease; subthalamic stimulation; dopamine; raclopride; PET;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1219 / 1223
页数：4
相关论文
共 50 条
  • [21] Effects of (S)-ketamine on striatal dopamine:: a [11C]raclopride PET study of a model psychosis in humans
    Vollenweider, FX
    Vontobel, P
    Oye, I
    Hell, D
    Leenders, KL
    JOURNAL OF PSYCHIATRIC RESEARCH, 2000, 34 (01) : 35 - 43
  • [22] Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET
    Hirvonen, Jussi
    Hietala, Jarmo
    Kajander, Jaana
    Markkula, Juha
    Rasi-Hakala, Helena
    Salminen, Jouko K.
    Nagren, Kjell
    Aalto, Sargo
    Karlsson, Hasse
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (10) : 1329 - 1336
  • [23] [11C]raclopride and extrastriatal binding to D2/3 receptors
    Backes, Heiko
    NEUROIMAGE, 2020, 207
  • [24] Effect of fluvoxamine on dopamine D2 receptors assessed by PEt and [11C]raclopride in drug naive obsessive compulsive patients
    Moresco, RM
    Locatelli, A
    Perani, D
    Panzacchi, A
    Bonaldi, L
    Matarrese, M
    Gobbo, C
    Belloli, S
    Bellodi, L
    Fazio, F
    NEUROIMAGE, 2004, 22 : T52 - T52
  • [25] Rostrocaudal distribution of D1 and D2 dopamine receptors in striatum with [11C]NNC-112 and [11C]Raclopride
    Rosa, P
    Cumming, P
    Munk, O
    Gjedde, A
    NEUROIMAGE, 2002, 16 (03) : S49 - S49
  • [26] 18F-Desmethoxyfallypride and PET is an alternative to 11C raclopride in characterizing D2 receptors in the different Parkinson syndromes
    Vogt, T
    Schreckenberger, M
    Siessmeier, T
    Roesch, F
    Hägele, S
    MOVEMENT DISORDERS, 2005, 20 : S145 - S146
  • [27] Striatal dopamine release during performance of executive functions:: A [11C] raclopride PET study
    Monchi, Oury
    Ko, Ji Hyun
    Strafella, Antonio P.
    NEUROIMAGE, 2006, 33 (03) : 907 - 912
  • [28] Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457
    Ikoma, Yoko
    Ito, Hiroshi
    Arakawa, Ryosuke
    Okumura, Masaki
    Seki, Chie
    Shidahara, Miho
    Takahashi, Hidehiko
    Kimura, Yuichi
    Kanno, Iwao
    Suhara, Tetsuya
    NEUROIMAGE, 2008, 42 (04) : 1285 - 1294
  • [29] Quantitative assessment of density and affinity for dopamine D2 receptors with multiple injections of [11C]raclopride
    Ikoma, Y.
    Watabe, H.
    Hayashi, T.
    Minato, K.
    Iida, H.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S348 - S349
  • [30] Long-term changes of striatal dopamine D-2 receptors in Parkinson's disease studied with PET and [C-11]raclopride
    Vontobel, P
    Antonini, A
    Leenders, KL
    Schwarz, J
    Oertel, WH
    NEUROLOGY, 1996, 46 (02) : 6086 - 6086
12345